Physician profile
Albert J Cook
NPI 1932134897
$3,367.93
in general payments reported to CMS, 2019-2025
11 companies · $2,396 in 2025
The $2,396 reported for 2025 was more than what 77% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.05 · 2020: $7.22 · 2021: $54.08 · 2022: $72.37 · 2023: $18.14 · 2024: $783 · 2025: $2,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780 · Travel and Lodging: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.41 |
| Travel and Lodging | $1,416.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,099.11 | 2024-2025 | Evolve, Surpass Evolve, Target |
| Boston Scientific Corporation | $357.69 | 2024 | Embold Fibered, Icefx Cryoablation System |
| Sequana Medical US INC. | $178.39 | 2025 | Alfapump System |
| Microvention, INC. | $173.95 | 2025 | Web Aneurysm Embolization System, Azur Cx Detachable, Balloon Catheter |
| W. L. Gore & Associates, INC. | $158.50 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Abbott Laboratories | $107.85 | 2024 | Diamondback Peripheral |
| Penumbra, INC. | $88.61 | 2019-2025 | Red 72, Penumbra System |
| Argon Medical Devices, INC. | $74.31 | 2025 | Clot Management |
| Sirtex Medical INC | $68.11 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $48.20 | 2021-2022 | |
| Ge Healthcare | $13.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.